(Updated - December 6, 2022 6:06 AM EST)

BTIG analyst Justin Zelin downgraded MEI Pharma (NASDAQ: MEIP) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE